A carregar...

Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure

Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response criteria based on changes of contrast enhancement (i.e., Macdonald criteria). Furthermore, more precise tumor response assessment criteria (i.e....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Galldiks, Norbert, Filss, Christian P., Goldbrunner, Roland, Langen, Karl-Josef
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3529567/
https://ncbi.nlm.nih.gov/pubmed/23271997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000342480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!